Warhound, a new company co-founded by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, has emerged from stealth with $200 million in funding to genetically engineer and equip dogs for U.S. military, law enforcement, and emergency response teams. The company aims to address the domestic supply of elite working dogs, according to Wired News.
The startup's funding round values Warhound at $1.2 billion, TechCrunch reported. Investors include Sequoia, 8VC, In-Q-Tel (a venture firm backed by the CIA and other U.S. intelligence agencies), and ARK Invest, Wired News added. The Verge noted that the Texas-based company plans to leverage Colossal's expertise in genetics, cloning, and animal biology to produce healthier canines.
Why it matters
Warhound's mission stems from a reported dwindling supply of working dogs for the U.S. military and law enforcement. More than 80 percent of these dogs are currently sourced from Europe, and less than half are deemed fit for service after a three-year acquisition and training process, according to Warhound's launch announcement, as cited by TechCrunch and The Verge. This reliance on foreign nations creates a dependency for animals critical in specialized operations such as bomb detection and searches, tasks often too dangerous for humans or difficult for machines.
Ben Lamm told TechCrunch that he researched the breeding of working dogs after a conversation with Palmer Luckey about a year ago. Lamm found that many existing working dogs do not complete training due to inherited health issues like poor eyesight, cancer predisposition, hip dysplasia, or muscle atrophy. Warhound intends to enhance dogs for improved health, longevity, speed, agility, and enhanced olfactory sensors.
The technology behind the dogs
Warhound plans to create a new type of dog by studying top-performing breeds such as the Belgian Malinois and German Shepherd, with some Labs also mentioned by Wired News. The company will collect cell lines or blood samples from these animals and edit their genes to improve performance characteristics while removing predispositions to common health problems, TechCrunch and Wired News reported. Colossal Biosciences, known for its de-extinction efforts, will support Warhound by licensing its technology. Viagen, another Colossal-owned company, will partner with Warhound for cloning, a process that Lamm stated has a high success rate.
Beyond genetic enhancements, Anduril will provide software and hardware to augment the dogs and their handlers. This includes items like advanced body armor, protection vests, goggles, and systems for situational awareness and coordination, according to TechCrunch and The Verge. The Verge specifically mentioned Anduril's EagleEye military technology. While Lamm clarified to Wired News that the current plan involves external tools rather than embedded computers, he emphasized that these additions aim to make the dogs safer, healthier, and better performing in the line of duty, which also protects human handlers.
Leadership and timeline
David Spirk, a former Department of Defense chief data officer who previously worked at Palantir, will serve as Warhound's chief executive, according to Wired News and The Verge. While Lamm is on the company's board, neither he nor Luckey will be involved in Warhound's day-to-day operations, Wired News reported. Bloomberg confirmed Luckey has no equity or ongoing role in Warhound, a detail also noted by TechCrunch and Wired News, though Colossal Biosciences does hold an ownership stake and licenses its technology to Warhound.
Warhound expects the first batch of puppies to be born in early 2027, with service ideally beginning within two years, TechCrunch and Wired News stated. The company aims to sell its dogs to first responders, the Department of Defense, military service groups, and police forces. Warhound is operating under the guidance of the American Humane Society to help certify its training program, and there is an aspiration for retired dogs to enter the Society's Military Working Dog Reunification Program, TechCrunch, Wired News, and The Verge indicated.
What remains unclear
While the company has briefed various government groups on its business, details regarding specific government approval processes for genetically engineered animals remain to be fully articulated, TechCrunch reported. The pricing structure for these specialized dogs has not yet been determined by Warhound. Future enhancements, such as potentially incorporating olfactory receptor genes from wolves, are envisioned further down the line, Wired News noted.
